Mizuho FinancialNYSE: MFG

Mizuho Financial Group, Inc. (NYSE:MFG ) Q2 2024 Results Earnings Conference Call November 16, 2024 1:30 AM ET Company Participants Orita Natsuki - Chief Investor Relationship Officer, General Manager of Investor Relationship Department Masahiro Kihara - President and Group Chief Executive Officer Takefumi Yonezawa - Group Chief Financial Officer Conference Call Participants Takahiro Yano - J.P. Morgan Securities Japan Co., Ltd.

The world has been primarily focused on the decisions made by the United States Federal Reserve (the Fed), particularly regarding interest rates and the state of the economy. Given that inflation has been tamed sufficiently, the Fed has decided to cut interest rates at the most aggressive pace in 16 years.

As US inflation shows signs of slowing, the prediction of a "soft landing" for the economy has become a prevalent view on Wall Street. However, Japan's third-largest bank, Mizuho, warns that if this prediction proves wrong, it could lead to short-term market volatility.

Mizuho (MFG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Mizuho Americas today announced that Thierry Perrein has joined as Managing Director and Credit Strategist. He primarily covers REITs and Non-bank Financials, complementing Mizuho's integrated offerings in these sectors. He reports to Brian Connors, Managing Director and Head of Investment Grade (IG) Trading within Mizuho Americas' Fixed Income Division.

WUXI and SUZHOU, China , Aug. 1, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that four manufacturing facilities and Suzhou Biosafety Testing Center in China have received Good Manufacturing Practice (GMP) certificates from the European Medicines Agency (EMA), demonstrating the company's commitment to meeting rigorous international industry quality standards across its global network. Following comprehensive inspections of the company's facilities– specifically MFG1, MFG2, MFG5, and DP1 in Wuxi– EMA GMP certificates were issued for commercial and New Drug Application (NDA)-ready manufacturing and services for eight biologics, an endorsement to the company's capabilities in providing such services for global clients.

Investors interested in stocks from the Banks - Foreign sector have probably already heard of Mizuho (MFG) and ICICI Bank Limited (IBN). But which of these two stocks is more attractive to value investors?

NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Mizuho Financial Group, Inc. hereby announces that it filed an annual report on Form 20-F with the U.S. Securities and Exchange Commission on June 26, 2024.

NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Mizuho Americas today announced the hiring of Steven Valiquette as Managing Director and Senior Equity Research Analyst, covering Health Care Technology & Distribution. Based in New York, Valiquette reports to the Head of Americas Equity Research, Bill Featherston.